Highlights Second Sight Medical Products

Equities

EYES

US81362J3086

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
1.26 ^USD	-0.79%		+0.80%	-44.74%

2022	Vivani Medical Starts Nasdaq Trading Lower	MT
2022	Second Sight Medical Products, Inc.(NasdaqCM:EYES) dropped from NASDAQ Composite Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Second Sight Medical Completes Merger With Nano Precision Medical; Changes Name to Vivani Medical	30/08/22	MT
Nano Precision Medical, Inc. completed the acquisition of Second Sight Medical Products, Inc. in a reverse merger transaction.	29/08/22	CI
Second Sight Medical Products Starts Trading on Split-Adjusted Basis; Shares Down	19/08/22	MT
Second Sight Medical Products, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22	CI
Second Sight Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
North American Morning Briefing : Dow Futures -2-	25/03/22	DJ
Second Sight Medical Products to Acquire Nano Precision Medical in All-Stock Deal	08/02/22	MT
Nano Precision Medical, Inc. entered into term sheet to acquire Second Sight Medical Products, Inc. for approximately $180 million in a reverse merger transaction.	06/02/22	CI
Second Sight Medical Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
Second Sight Medical Products, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/08/21	CI
North American Morning Briefing : Retail Sales -3-	16/07/21	DJ
Second Sight Medical Products : Plans Public Offering of Stock to Fund Artificial Vision Device	22/06/21	MT
Second Sight Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/05/21	CI
Pixium Vision : Mulls Legal Action as Second Sight Terminates Merger Talks; Stock Falls 8%	06/04/21	MT
Assets and Liabilities in relation to neuromodulation technology of Pixium Vision SA cancelled the acquisition of Second Sight Medical Products, Inc. in a reverse merger transaction.	01/04/21	CI
Second Sight Medical Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	16/03/21	CI
Second Sight Medical Products, Inc. Receives U.S. Food and Drug Administration Approval for the Argus 2s Retinal Prosthesis System	05/03/21	CI
Assets and Liabilities in relation to neuromodulation technology of Pixium Vision SA signed a definitive agreement to acquire Second Sight Medical Products, Inc. for $77.8 million in a reverse merger transaction.	05/01/21	CI
Second Sight Medical Products, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	12/11/20	CI
Second Sight Medical Products Inc. Announces Resumption of Its Early Feasibility Study of the Orion® Cortical Visual Prosthesis at UCLA	22/09/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Second Sight Medical Products

Equities

EYES

US81362J3086

Highlights

Filters